GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Siemens Healthineers AG (OTCPK:SEMHF) » Definitions » 3-Year ROIIC %

Siemens Healthineers AG (Siemens Healthineers AG) 3-Year ROIIC % : 1.49% (As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Siemens Healthineers AG 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Siemens Healthineers AG's 3-Year ROIIC % for the quarter that ended in Sep. 2023 was 1.49%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Siemens Healthineers AG's 3-Year ROIIC % or its related term are showing as below:

SEMHF's 3-Year ROIIC % is ranked better than
53.01% of 830 companies
in the Medical Devices & Instruments industry
Industry Median: -0.99 vs SEMHF: 1.49

Siemens Healthineers AG 3-Year ROIIC % Historical Data

The historical data trend for Siemens Healthineers AG's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Siemens Healthineers AG 3-Year ROIIC % Chart

Siemens Healthineers AG Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only 7.03 -3.65 2.34 2.05 1.49

Siemens Healthineers AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 1.49 -

Competitive Comparison of Siemens Healthineers AG's 3-Year ROIIC %

For the Medical Devices subindustry, Siemens Healthineers AG's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Siemens Healthineers AG's 3-Year ROIIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Siemens Healthineers AG's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Siemens Healthineers AG's 3-Year ROIIC % falls into.



Siemens Healthineers AG 3-Year ROIIC % Calculation

Siemens Healthineers AG's 3-Year ROIIC % for the quarter that ended in Sep. 2023 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( 1800.643474 (Sep. 2023) - 1666.2532581 (Sep. 2020) )/( 41336.18 (Sep. 2023) - 24064.782 (Sep. 2020) )
=134.3902159/17271.398
=0.78%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Siemens Healthineers AG  (OTCPK:SEMHF) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Siemens Healthineers AG 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Siemens Healthineers AG's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Siemens Healthineers AG (Siemens Healthineers AG) Business Description

Address
Siemensstr. 3, Forchheim, BY, DEU, 91301
Siemens Healthineers AG is engaged in the fields of diagnostic, therapeutic imaging, laboratory and point of care diagnostics as well as clinical consulting services. The imaging segment products equipment include magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging and ultrasound. The portfolio of the Diagnostics segment includes; immunochemistry, hematology, coagulation, urinalysis, etc. Advanced Therapies segment products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology and surgery. Varian segment provides multi-modality cancer care technologies, solutions and services to oncology departments in hospitals and clinics. It caters and earns revenue from Europe, the Middle East, Africa, China and others.